Amarin Corp Plc (AMRN)

[Whalatane]

North. Thx I know that .
What I was looking for were concise responses . I am not able to send a 5 page argument . I'm limited to a set number of letters in my email responses thru Kaiser .

Poster Atom has directed me to some concise responses ....on Amarin's web site
Kiwi

PS. I just saw your links ...thx ...will go thru them

PPS. in listening to Dr Bhatt .....he describes R-IT as over 60% secondary prevention and the rest primary prevention . The primary prevention group being mainly diabetics with one additional risk factor .

My Cardiologist's argument is that if he were to prescribe Vascepa to me .. he would only prescribe it if I were a
1) Secondary prevention patient. ..ie prior MI etc
2) Diabetic with 1 additional risk factor

That is different from my understanding of the NLA statement ...which was clinical ASCVD , Tg's over 135 , optimal statin therapy .
Can you be clinical ASCVD without having a prior event ?...my understanding is that you can >
Whats your opinion